NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

BMC Cancer · 2015 · PMC4329217 · PMID 25880814

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

of borderline significancep = 0.053so close (0.05 < p ≤ 0.1)

In the Urschel meta-analysis, there was a non-significant increase in peri-operative mortality [1.72 (0.96, 3.07; p = 0.07)] and increase in all-treatment mortality that was of borderline significance [1.63 (0.99, 2.68; p = 0.053)] [ 8 ].

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.